Agios Reports Fourth Quarter and Full Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Agios Pharma (AGIO) PT Lowered to $96 at H.C. Wainwright
February 24, 2022 12:27 PM ESTH.C. Wainwright analyst Michael King lowered the price target on Agios Pharma (NASDAQ: AGIO) to $96.00 (from $98.00) while maintaining a Buy rating.
... MoreAgios Pharma (AGIO) Misses Q4 EPS by 7c
February 24, 2022 7:04 AM ESTAgios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.74), $0.07 worse than the analyst estimate of ($1.67).
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... More